Martlet Capital Limited (“Martlet Capital”) is excited to announce an initial equity investment from high calibre investors, including Saranac Partners and NetScientific, the parent company of EMV Capital. This investment will allow Martlet Capital to acquire the existing portfolio of over 50 investments from Marshall of Cambridge (Holdings) Limited and continue to invest in UK based deep technology businesses. The...
Martlet Capital is the investment arm of the Marshall of Cambridge group and has invested in more than 50 start-ups, since its launch in 2011.
We provide patient capital for early-stage B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge.
Our team is comprised of experienced investors and entrepreneurs. In addition to capital, we can offer support, experience and a network of contacts.
We have achieved several exits from our portfolio, from trade sales to global technology companies and IPO’s.
Martlet Capital is part of the Marshall Group, an ambitious privately owned company founded in 1909. Headquartered on a 900-acre site in Cambridge.
We seek to support entrepreneurs with value beyond capital. We have experience of helping companies scale from first-round through to exit.
added by Alan Cowley 2 min Read
Hemant Mardia joins quantum photonics pioneer Nu Quantum as Chair Track record in commercialising deep tech semiconductor solutions at Filtronic Plc, IDEX ASA and as Chair at Blu Wireless, bringing significant experience to Nu Quantum as it develops its commercial strategy for quantum photonic enabled products.added by Alan Cowley 2 min Read
Investors have rewarded the commercial success of Spotta's smart pest systems with a $1.18 million seed funding round.added by Alan Cowley 3 min Read
Cambridge GaN Devices Ltd. (CGD) leads €10.3M project with 13 European partners to deliver the most energy-efficient GaN power modules.added by Alan Cowley 3 min Read